Skip to main content
无锡晶海 logo

无锡晶海 — Investor Relations & Filings

Ticker · 920547 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2024-01-22 Governance Information
Country CN China
Listing Beijing Stock Exchange 920547

About 无锡晶海

https://www.chinaaminoacid.com/

Wuxi Jinghai Amino Acid Co., Ltd. specializes in the research, development, and large-scale production of high-purity amino acids through microbial fermentation. The company’s core product portfolio includes L-Isoleucine, L-Valine, L-Leucine, L-Proline, and L-Threonine, which serve as critical raw materials for the pharmaceutical, nutritional, and food processing sectors. Utilizing advanced biotechnological processes, the firm maintains rigorous quality control standards, holding certifications such as GMP, ISO, HALAL, and KOSHER. Its products are primarily utilized in the formulation of parenteral nutrition, specialized medical foods, and high-end supplements. The company focuses on technological innovation to optimize fermentation yields and purity levels, positioning itself as a key supplier in the global amino acid supply chain.

Recent filings

Filing Released Lang Actions
承诺管理制度
Governance Information Classification · 95% confidence The document is a detailed management system or policy document titled '承诺管理制度' (Commitment Management System) issued by the company 无锡晶海氨基酸股份有限公司. It outlines the rules, responsibilities, and procedures related to commitments made by the company and related parties, including legal references and governance procedures. It is not a financial report, earnings release, or announcement of voting results. It is also not a short announcement or certification but a substantive governance-related document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2024-01-22 Chinese
东方证券承销保荐有限公司关于无锡晶海氨基酸股份有限公司使用闲置募集资金进行现金管理的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed opinion and verification report from the sponsor (东方证券承销保荐有限公司) regarding the use of idle raised funds by 无锡晶海氨基酸股份有限公司 for cash management. It references regulatory approvals, fundraising amounts, investment projects, risk analysis, and the approval process by the board and supervisory committee. The document is not a full financial report like an Annual Report or Interim Report, nor is it a brief announcement. It is a formal verification and opinion report related to the use of capital raised through a public offering. This fits the category of a Capital/Financing Update (CAP), as it provides detailed information on fundraising, use of proceeds, and compliance with regulatory requirements regarding the raised capital. The document length is 3556 characters, which is substantive but not a full financial report. Therefore, the best classification is CAP with high confidence.
2024-01-22 Chinese
关于增加经营范围完成工商登记的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of business scope expansion and the completion of industrial and commercial registration. It includes details about the company's updated business license and registration information. The document is short (966 characters) and serves as an official notice of a corporate action rather than a financial report or detailed filing. There is no financial data, no mention of annual or interim reports, no audit information, no management discussion, or other report types. It is a regulatory announcement about corporate registration changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-01-18 Chinese
无锡晶海氨基酸股份有限公司关于超额配售选择权实施结果的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the implementation results of an over-allotment option (超额配售选择权) related to a stock issuance by Wuxi Jinghai Amino Acid Co., Ltd. It details the number of shares issued, the increase in total shares, the allocation to strategic investors, and the completion of funds raised. It also includes a verification report from an accounting firm on the capital raised. The document is relatively short (3283 characters) and focuses on the outcome of a capital raising event rather than providing comprehensive financial statements or detailed financial performance data. This fits the definition of a Capital/Financing Update (CAP) rather than a full Annual Report, Interim Report, or Earnings Release. Therefore, the correct classification is Capital/Financing Update (CAP).
2024-01-14 Chinese
上海市浦栋律师事务所关于无锡晶海氨基酸股份有限公司向不特定合格投资者公开发行股票并在北京证券交易所上市超额配售选择权实施事项之专项法律意见书
Capital/Financing Update Classification · 95% confidence The document is a specialized legal opinion letter issued by a law firm regarding the implementation of an over-allotment option (greenshoe option) related to a public stock issuance and listing on the Beijing Stock Exchange by Wuxi Jinghai Amino Acid Co., Ltd. It details the legal compliance, internal approvals, share allotment, and funds raised from the over-allotment option. The document is not a financial report, earnings release, or management discussion but a legal opinion on a capital issuance event. It is not a brief announcement but a detailed legal opinion letter. This fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length (5422 characters) and content confirm it is a substantive legal opinion on a financing event, not a mere announcement or certification. Therefore, the classification is CAP with high confidence.
2024-01-10 Chinese
无锡晶海氨基酸股份有限公司超额配售选择权实施公告
Capital/Financing Update Classification · 95% confidence The document is titled as an "超额配售选择权实施公告" which translates to "Over-allotment Option Implementation Announcement." It details the exercise of an over-allotment option related to a public stock issuance by Wuxi Jinghai Amino Acid Co., Ltd. The text includes specifics about the number of shares issued, pricing, strategic investors, and legal and regulatory compliance confirmations. There is no presentation of financial statements or detailed financial performance data, but rather a formal announcement of the completion and details of a capital issuance event. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is under 5,000 characters, but it contains substantive details about the capital issuance, not merely a notice of report publication. Therefore, the correct classification is CAP with high confidence.
2024-01-10 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.